More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries

Abstract

Although current value frameworks and economic models have allowed us to better quantify the net benefit associated with cancer therapy, holistic cancer care must consider patient time, family and social values, and overall life expectancy. Training programs must include training in health services research, difficult conversations, and shared decision-making strategies that are developed in social and cultural frameworks for their settings.

Keywords: Clinical trials; Essential medicines; LMICs; Prediction tools.